Global Bio-Pharma Leader
Distributing temperature-sensitive vaccines and biological therapies across 12 European nations presented severe cold-chain risks for the client. Requiring strict temperature stability across multiple bands (-70°C deep freeze, -20°C, and +2°C to +8°C), any temperature excursion during cross-border customs stops or transit delays could compromise drug potency and lead to complete batch loss.
LOGISTEED designed a GDP-compliant cold-chain network powered by central distribution hubs in Frankfurt and Amsterdam. Operating a dual-redundant active reefer truck fleet alongside validated thermal packaging and continuous Control Tower telemetry, LOGISTEED guaranteed unbroken thermal protection from manufacturing facility to medical center.
Summary of How LOGISTEED Helped:
The contract covered end-to-end cold storage, packaging, customs clearance, and last-mile distribution across Western and Eastern European medical facilities.
Scope of services delivered:
Transporting biological products across European borders required navigating strict Good Distribution Practice (GDP) regulations, varying customs regimes, and unexpected transit delays.
A single temperature deviation beyond established stability limits could compromise drug potency and result in complete batch destruction.
END RESULTS: Temperature-Controlled Vaccine & Biologics Distribution in Europe
LOGISTEED implemented active GPS telemetry sensors inside every thermal container, feeding real-time location and temperature data to a centralized Control Tower.
Tailored features included:
We fuse precise engineering with specialized operational infrastructure to optimize supply chains across five core global sectors.












Discover how we combine deep Japanese engineering discipline with advanced digital twin analytics to solve complex supply chain challenges globally.


